Virtue is an earliest-stage healthcare venture capital firm that exclusively invests in pre-seed and seed rounds. The firm focuses on digital health and healthcare technology innovations that aim to radically transform the healthcare ecosystem.
50% of their portfolio is in Healthcare. Their most common stage is series-a (50% of deals). Average disclosed round size is $23.9M (across 5 rounds with reported amounts).
Portfolio
6
Fund Size
$87M
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| GGyde | Series C | $60M | Jan 2026 |
| PPrudentia Sciences | Series A | $20M | Jan 2026 |
 Solstice Health | Seed | $3.5M | Feb 2025 |
 Seen Health | Series A | $22M | Nov 2024 |
 Evvy | Series A | $14M | Sep 2023 |
 Synthetica Bio | Seed | — | Jun 2023 |
Top Co-Investors
Lightspeed Venture Partners1 shared
Optum Ventures1 shared
MVP Ventures1 shared
Left Lane Capital1 shared
General Catalyst1 shared
Labcorp1 shared
RH Capital1 shared
Ingeborg Investments1 shared
G9 Ventures1 shared
Amboy Street Ventures1 shared
8VC1 shared
Basis Set Ventures1 shared
Primetime Partners1 shared
McKesson Ventures1 shared
SignalFire1 shared
GV (Google Ventures)1 shared
Last updated: 21 April 2026